XML 66 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Jan. 01, 2024
Sep. 30, 2022
Net cash provided by operating activities          
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 548.9 $ 607.9 $ 1,025.7    
Adjustments to reconcile net income to net cash provided by operating activities:          
Stock-based compensation 214.8 246.1 182.6    
Amortization of deferred sales commissions 79.8 62.0 50.0    
Depreciation and other amortization 125.3 116.5 104.3    
Amortization of intangible assets 406.5 338.2 341.1    
Impairment of intangible asset 226.6 389.2 0.0    
Net losses (gains) on investments 37.6 (57.6) (39.5)    
Income from investments in equity method investees (78.0) (137.5) (45.4)    
Net (gains) losses on investments of consolidated investment products (4.1) 24.9 120.4    
Net purchase of investments by consolidated investment products (369.4) (520.2) (829.4)    
Deferred income taxes (47.2) (124.6) 41.5    
Other 174.4 172.2 73.2    
Changes in operating assets and liabilities:          
Increase in receivables and other assets (128.7) (111.8) (63.2)    
Decrease in investments, net 19.0 9.4 2.8    
Increase (decrease) in accrued compensation and benefits (32.9) 86.5 128.9    
Decrease in income taxes payable (181.5) (93.4) (1.1)    
Increase (decrease) in accounts payable, accrued expenses and other liabilities 90.0 3.9 (4.5)    
Increase (decrease) in accounts payable and accrued expenses of consolidated investment products (15.0) (40.4) 1.8    
Net cash provided by operating activities 1,066.1 971.3 1,089.2    
Net cash used in investing activities          
Purchase of investments (1,037.2) (1,127.7) (757.8)    
Liquidation of investments 776.2 1,406.8 608.6    
Purchase of investments by consolidated collateralized loan obligations (6,538.9) (6,310.0) (4,364.1)    
Payments of deferred consideration liability (90.5) (534.9) (241.8)    
Liquidation of investments by consolidated collateralized loan obligations 4,918.6 4,250.7 1,834.1    
Additions of property and equipment, net (154.5) (177.1) (148.8)    
Acquisitions, net of cash acquired (including $281.4 in cash and cash equivalents of consolidated investment products in fiscal year 2024) 0.0 175.1 (500.5)    
Payments of contingent consideration asset 0.0 0.0 9.8    
Net deconsolidation of investment products (216.4) (106.6) (49.8)    
Net cash used in investing activities (2,342.7) (2,423.7) (3,610.3)    
Net cash provided by financing activities          
Issuance of common stock 24.1 20.8 23.3    
Dividends paid on common stock (683.7) (656.4) (607.3)    
Repurchase of common stock (240.3) (274.4) (256.3)    
Proceeds from repurchase agreement 144.7 5.3 174.8    
Payments on repurchase agreement (61.8) (81.1) 0.0    
Proceeds from debt 300.0 0.0 0.0    
Payments on debt (700.0) (250.0) (300.0)    
Proceeds from debt of consolidated investment products 6,029.7 4,346.7 3,539.9    
Payments on debt by consolidated investment products (4,800.6) (1,912.9) (1,105.0)    
Payments on contingent consideration liabilities (6.8) (22.8) (7.6)    
Noncontrolling interests 447.1 240.4 644.9    
Net cash provided by financing activities 452.4 1,415.6 2,106.7    
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation (10.8) 43.3 34.3    
Increase (decrease) in cash and cash equivalents (835.0) 6.5 (380.1)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3,573.9 4,408.9 4,402.4   $ 4,782.5
Supplemental Disclosure of Cash Flow Information          
Cash paid for income taxes 465.4 435.7 233.2    
Cash paid for interest 106.6 113.4 121.9    
Cash paid for interest by consolidated investment products 753.2 694.2 379.2    
Noncash or Part Noncash Acquisition, Investments Acquired 68.4 0.0 $ 0.0    
Consolidated Investment Products [Member]          
Net cash provided by financing activities          
Cash and cash equivalents, beginning of year 1,099.4        
Cash and Cash Equivalents, End of Year $ 485.8 $ 1,099.4      
Consolidated Investment Products [Member] | Putnam Investments          
Supplemental Disclosure of Cash Flow Information          
Cash and cash equivalents       $ 281.4  
Cash and cash equivalents       $ 281.4